Viewing Study NCT06567366


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2025-12-24 @ 4:07 PM
Study NCT ID: NCT06567366
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-22
First Post: 2024-08-20
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module